New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to...
CHONGQING, China, May 23, 2026 /PRNewswire/ -- A news report from iChongqing - Chongqing Qianxin Foreign Trade and Economic Cooperation Group (CFTEC) and AEOTrade co-hosted...
ANSHUN, China, May 23, 2026 /PRNewswire/ -- On May 21, at the Guizhou Anshun Tourism Development Conference, Mafengwo Travel Group officially launched three flagship "New...
SHANGHAI, May 23, 2026 /PRNewswire/ -- For many participants in the innovative drug discovery arena, AI-STAL and SAI-DA are already familiar names within the Sanyou...